Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 12, 2021
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
[ Thu, Aug 12th 2021
] - WOPRAI
Wed, August 11, 2021
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
[ Wed, Aug 11th 2021
] - WOPRAI
Robert Burns Maintained (BNTX) at Hold with Increased Target to $330 on, Aug 11th, 2021
Robert Burns of HC Wainwright & Co., Maintained "BioNTech SE" (BNTX) at Hold with Increased Target from $194 to $330 on, Aug 11th, 2021.
Robert has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 2 agree with Robert's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Chris Shibutani of "Goldman Sachs" Initiated at Hold and Held Target at $173 on, Tuesday, May 18th, 2021
- Daina Graybosch of "SVB Leerink" Maintained at Hold with Increased Target to $159 on, Tuesday, May 11th, 2021
These are the ratings of the 2 analyists that currently disagree with Robert
- Simon Baker of "Redburn Partners" Downgraded from Hold to Strong Sell on, Wednesday, June 16th, 2021
- Arlinda Lee of "Canaccord Genuity" Maintained at Strong Buy with Increased Target to $240 on, Thursday, May 13th, 2021
